Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ROCKET PHARMACEUTICALS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 54K | $678K | $12.55 | Feb 14, 2022 | Direct |
ROCKET PHARMACEUTICALS, INC. | Chief Financial Officer | Restricted Stock Units | 17.3K | $390K | $22.53 | Feb 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RCKT | ROCKET PHARMACEUTICALS, INC. | Feb 14, 2022 | 2 | $0 | 4 | Feb 16, 2022 | Chief Financial Officer |
RCKT | ROCKET PHARMACEUTICALS, INC. | Sep 13, 2021 | 1 | $0 | 4 | Sep 15, 2021 | Chief Financial Officer |